CorMedix, a biopharmaceutical company specialising in critical care products, has signed an agreement to acquire Melinta ...

Discover key insights from Cytokinetics' Q2 2025 earnings call, including aficamten’s regulatory progress, launch plans, clinical milestones, and ...

CorMedix to acquire biopharma company, Melinta Therapeutics in $300 million deal: Berkeley Heights, New Jersey Friday, August 8, 2025, 14:00 Hrs [IST] CorMedix Inc. (CorMedix), a ...

Detailed price information for Royalty Pharma Plc Cl A (RPRX-Q) from The Globe and Mail including charting and trades.

Key Points GAAP revenue surged to $66.8 million in Q2 2025, driven by recognition of one-time license and milestone payments, exceeding analyst estimates by 3,065.9% (GAAP). GAAP loss per share ...

A 58-year-old man presents for a routine annual physical. During the exam, he mentions an intermittent sensation like a “rush of anxiety” that begins in the abdomen and chest and radiates to the head.

Small amounts of red wine may not affect your blood pressure, but drinking lots of red wine will raise it, which comes with ...

Transformational deal for CorMedix that expands and diversifies company’s commercial product portfolio, with seven innovative drug products and a pipeline expansion indication with near-term revenue ...